Follow
Albert Pares
Albert Pares
Liver Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain
Verified email at ub.edu
Title
Cited by
Cited by
Year
Simplified criteria for the diagnosis of autoimmune hepatitis
EM Hennes, M Zeniya, AJ Czaja, A Parés, GN Dalekos, EL Krawitt, ...
Hepatology 48 (1), 169-176, 2008
19182008
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
A Parés, L Caballería, J Rodés
Gastroenterology 130 (3), 715-720, 2006
8242006
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial
JM Mato, J Cámara, JF De Paz, L Caballería, S Coll, A Caballero, ...
Journal of hepatology 30 (6), 1081-1089, 1999
6681999
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid
GM Hirschfield, A Mason, V Luketic, K Lindor, SC Gordon, M Mayo, ...
Gastroenterology 148 (4), 751-761. e8, 2015
6082015
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: the RELIEF trial
R Bañares, F Nevens, FS Larsen, R Jalan, A Albillos, M Dollinger, ...
Hepatology 57 (3), 1153-1162, 2013
5422013
Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial
A Parés, R Planas, M Torres, J Caballería, JM Viver, D Acero, J Panés, ...
Journal of hepatology 28 (4), 615-621, 1998
4731998
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study
WJ Lammers, HR Van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ...
Gastroenterology 147 (6), 1338-1349. e5, 2014
4312014
Short-and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial
E Cabré, P Rodrı́guez-Iglesias, J Caballerı́a, JC Quer, ...
Hepatology 32 (1), 36-42, 2000
4142000
Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’
U Beuers, ME Gershwin, RG Gish, P Invernizzi, DEJ Jones, K Lindor, ...
Gut 64 (11), 1671-1672, 2015
3892015
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ...
Nature genetics 45 (6), 670-675, 2013
3832013
Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy
WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ...
Gastroenterology 149 (7), 1804-1812. e4, 2015
3702015
Histological course of alcoholic hepatitis: influence of abstinence, sex and extent of hepatic damage
A Parés, J Caballería, M Bruguera, M Torres, J Rodés
Journal of hepatology 2 (1), 33-42, 1986
3431986
Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis
TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ...
Gastroenterology 152 (8), 1975-1984. e8, 2017
3422017
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial
A Parés, L Caballería, J Rodés, M Bruguera, L Rodrigo, A García-Plaza, ...
Journal of hepatology 32 (4), 561-566, 2000
3392000
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation
KM Boberg, A Bergquist, S Mitchell, A Pares, F Rosina, U Broome, ...
Scandinavian journal of gastroenterology 37 (10), 1205-1211, 2002
3152002
Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury
A Parés, JM Barrera, J Caballería, G Ercilla, M Bruguera, L Caballería, ...
Hepatology 12 (6), 1295-1299, 1990
3041990
Effects of long-term rifampicin administration in primary biliary cirrhosis
L Bachs, A Parés, M Elena, C Piera, J Rodés
Gastroenterology 102 (6), 2077-2080, 1992
2761992
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis
RE Poupon, KD Lindor, A Parés, O Chazouillères, R Poupon, ...
Journal of hepatology 39 (1), 12-16, 2003
2672003
Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis
L Bachs, M Elena, A Parés, C Piera, J Rodés
The Lancet 333 (8638), 574-576, 1989
2561989
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
KV Kowdley, V Luketic, R Chapman, GM Hirschfield, R Poupon, ...
Hepatology 67 (5), 1890-1902, 2018
2202018
The system can't perform the operation now. Try again later.
Articles 1–20